Nudicauline and elatine as potent norditerpenoid ligands at rat neuronal α-bungarotoxin binding sites: Importance of the 2-(methylsuccinimido)benzoyl moiety for neuronal nicotinic acetylcholine receptor binding

Journal of Medicinal Chemistry

Volumn 39, Issue 24, 1996, Pages 4860-4866

  Hardick, David J ^a   Blagbrough, Ian S ^a   Cooper, Gary ^a   Potter, Barry V L ^a   Critchley, Trevor ^b   Wonnacott, Susan ^b  

^a University of Bath   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONDELPHINE; DELCORINE; DELSOLINE; DITERPENOID; ELATINE; ERGOCALCIFEROL; INULIN; KARACOLINE; LAPPACONITINE; LYCOCTONINE; METHYLCACONITINE; NICOTINIC RECEPTOR; NUDICAULINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

ACONITINE; ALKALOIDS; ANIMALS; BINDING SITES; BINDING, COMPETITIVE; BRAIN; BUNGAROTOXINS; CELL MEMBRANE; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; RATS; RECEPTORS, NICOTINIC; STRUCTURE-ACTIVITY RELATIONSHIP; SUCCINIMIDES;

EID: 0030474553     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9604991     Document Type: Article

References (37)

1. Goodson, J. A. The alkaloids of the seeds of Delphinium elatum. J. Chem. Soc. 1943, 139-141.
2. Coates, P. A.; Blagbrough, I. S.; Hardick, D. J.; Rowan, M. G.; Wonnacott, S.; Potter, B. V. L. Rapid and efficient isolation of the nicotinic receptor antagonist methyllycaconitine from Delphinium: assignment of the methylsuccinimide absolute stereochemistry as S. Tetrahedron Lett. 1994, 35, 8701-8704.
3. Wonnacott, S.; Albuquerque, E. X.; Bertrand, D. Methyllycaconitine: a new probe that discriminates between nicotinic acetylcholine receptor subclasses. In Methods in Neurosciences; Conn, M., Ed.; Academic Press: New York, 1993; Vol. 12, pp 263-275.
4. Barrantes, G. E.; Rogers, A. T.; Lindstrom, J.; Wonnacott, S. α-Bungarotoxin binding sites in rat hippocampal and cortical cultures: initial characterisation, colocalisation with α7 subunits and up-regulation by chronic nicotine treatment. Brain Res. 1995, 672, 228-236.
5. Alkondon, M.; Pereira, E. F. R.; Wonnacott, S.; Albuquerque, E. X. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol. Pharmacol. 1992, 41, 802-808.
6. Ward, J. M.; Cockcroft, V. B.; Lunt, G. G.; Smillie, F. S.; Wonnacott, S. Methyllycaconitine: a selective probe for neuronal α-bungarotoxin binding sites. FEBS Lett. 1990, 270, 45-48.
7. Palma, E.; Bertrand, S.; Binzoni, T.; Bertrand, D. Neuronal nicotinic α7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. J. Physiol. 1996, 491.1, 151-161.
8. McGehee, D. S.; Role, L. W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu. Rev. Physiol. 1995, 57, 521-546.
9. Elgoyhen, A. B.; Johnson, D. S.; Boulter, J.; Vetter, D. E.; Heinemann, S. α9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 1994, 79, 705-715.
10. Dale, H. H. The action of certain esters and ethers of choline, and their relation to muscarine. J. Physiol. (London) 1914, 6, 147-190.
11. Heinemann, T.; Changeux, J. P. Structural and functional properties of the acetylcholine receptor in its purified and membrane-bound states. Annu. Rev. Biochem. 1978, 47, 317-357.
12. Clarke, P. B. S. The fall and rise of neuronal α-bungarotoxin binding proteins. Trends Pharmacol. Sci. 1992, 13, 407-413.
13. Pelletier, S. W.; Joshi, B. S. Carbon-13 and proton NMR shift assignments and physical constants of norditerpenoid alkaloids. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; Springer Verlag: New York, 1991; Vol. 7, pp 297-564.
14. Yunusov, M. S. Diterpenoid alkaloids. Nat. Prod. Rep. 1991, 8, 499-526.
15. Yunusov, M. S. Diterpenoid alkaloids. Nat. Prod. Rep. 1993, 10, 471-486.
16. Benn, M. H.; Jacyno, J. M. The toxicology and pharmacology of diterpenoid alkaloids. In Alkaloids: Chemical and Biological Perspectives; Pelletier, S. W., Ed.; John Wiley and Sons: New York, 1983; Vol. 1, pp 153-210.
17. Jacyno, J. M.; Harwood, J. S.; Lin, N.-H.; Campbell, J. E.; Sullivan, J. P.; Holladay, M. W. Lycaconitine revisited: partial synthesis and neuronal nicotinic acetylcholine receptor affinities. J. Nat. Prod. 1996, 59, 707-709.
18. Hardick, D. J.; Cooper, G.; Scott-Ward, T.; Blagbrough, I. S.; Potter, B. V. L.; Wonnacott, S. Conversion of the sodium channel activator aconitine into a potent α7-selective nicotinic ligand. FEBS Lett. 1995, 365, 79-82.
19. Coates, P. A.; Blagbrough, I. S.; Lewis, T.; Potter, B. V. L.; Rowan, M. G. An HPLC assay for the norditerpenoid alkaloid methyllycaconitine, a potent nicotinic acetylcholine receptor antagonist. J. Pharm. Biomed. Anal. 1993, 13, 1541-1544.
20. Rabinovich, M. S. Aconitine alkaloids. VI. Elatine. J. Gen. Chem. USSR 1954, 24, 2211-2213; Chem. Abstr. 1957, 51, 16503g.
21. Rabinovich, M. S. Aconitine alkaloids. VI. Elatine. J. Gen. Chem. USSR 1954, 24, 2211-2213; Chem. Abstr. 1957, 51, 16503g.
22. 19-diterpenoid alkaloids: partial synthesis of delbruline, and elatine. Heterocycles 1987, 26, 2835-2840.
23. 1H-NMR spectra of norditerpenoid alkaloids a review. J. Nat. Prod. 1994, 57, 1473-1483.
24. Blagbrough, I. S.; Coates, P. A.; Hardick, D. J.; Lewis, T.; Rowan, M. G.; Wonnacott, S.; Potter, B. V. L. Acylation of lycoctonine: semi-synthesis of inuline, delsemine analogues and methyllycaconitine. Tetrahedron Lett. 1994, 35, 8705-8708.
25. Beers, W. H.; Reich, E. Structure and activity of acetylcholine. Nature 1970, 228, 917-922.
26. Manners, G. D.; Panter, K. E.; Pelletier, S. W. Structure-activity relationships of norditerpenoid alkaloids occuring in toxic lark-spur (Delphinium) species. J. Nat. Prod. 1995, 58, 863-869.
27. Pelletier, S. W.; Bhattacharyya, J. The nature of "delsemine" from Delphinium semibarbatum and D. tricorne Michaux (Dwarf Larkspur). Tetrahedron Lett. 1977, 2735-2736.
28. Kukel, C. F.; Jennings, K. R. Delphinium alkaloids as inhibitors of α-bungarotoxin binding to rat and insect neural membranes. Can. J. Physiol. Pharmacol. 1994, 72, 104-107; 1995, 73, 145.
29. Kukel, C. F.; Jennings, K. R. Delphinium alkaloids as inhibitors of α-bungarotoxin binding to rat and insect neural membranes. Can. J. Physiol. Pharmacol. 1994, 72, 104-107; 1995, 73, 145.
30. Sheridan, R. P.; Nilakantan, R.; Dixon, J. S.; Venkataraghavan, R. The ensemble approach to distance geometry: application to the nicotinic pharmacophore. J. Med. Chem. 1986, 29, 899-906.
31. Drasdo, A.; Caulfield, M. P.; Bertrand, D.; Bertrand, S.; Wonnacott, S. Methyllycaconitine: a novel nicotinic antagonist. Mol. Cell. Neurosci. 1992, 3, 237-243.
32. Flores, C. M.; Rogers, S. W.; Pabreza, L. A.; Wolfe, B. B.; Kellar, K. J. A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment. Mol. Pharmacol. 1992, 41, 31-37.
33. Sargent, P. B. The diversity of neuronal nicotinic acetylcholine receptors. Annu. Rev. Neurosci. 1993, 16, 403-443.
34. McDonald, I. A.; Cosford, N.; Vernier, J.-M. Nicotinic acetylcholine receptors: molecular biology, chemistry and pharmacology. Annu. Rep. Med. Chem. 1995, 30, 41-50.
35. Dictionary of Organic Compounds, 5th ed.; Chapman and Hall: New York, 1982; Vol. 3, p 3370.
36. CRC Handbook of Chemistry and Physics, 71st ed.; Lide, D. R., Ed.; CRC Press: Boca Raton, FL, 1990; p 3-295.
37. Garcha, H. S.; Thomas, P.; Spivak, C. E.; Wonnacott, S.; Stolerman, I. P. Behavioural and ligand-binding studies in rats with 1-acetyl-4-methylpiperazine, a novel nicotinic agonist. Psychopharmacology 1993, 110, 347-354.